Medivation Announces Fourth Quarter and Year-End 2012 Financial Results Teleconference on February 28, 2013
(firmenpresse) - SAN FRANCISCO, CA -- (Marketwire) -- 02/14/13 -- Medivation, Inc. (NASDAQ: MDVN) today announced that it will host a live teleconference with management to discuss fourth quarter and year-end 2012 financial results and provide a general business update on February 28, 2013 at 4:30 p.m. Eastern Time. A press release for the fourth quarter and year-ended 2012 will be released after markets close on February 28, 2013.
Interested parties may listen to the live teleconference by calling 877-303-2523 from the U.S. or +1-253-237-1755 internationally. Individuals may access the live audio webcast by visiting: . A replay of the webcast will be available on the Company's website for 30 days following the live event.
Medivation, Inc. is a biopharmaceutical company focused on the rapid development of novel therapies to treat serious diseases for which there are limited treatment options. Medivation aims to transform the treatment of these diseases and offer hope to critically ill patients and their families. For more information, please visit us at .
Patrick Machado
Chief Business & Financial Officer
(415) 829-4101
Anne Bowdidge
Sr. Director, Investor Relations
(650) 218-6900
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Datum: 14.02.2013 - 15:10 Uhr
Sprache: Deutsch
News-ID 1197348
Anzahl Zeichen: 0
contact information:
Contact person:
Town:
SAN FRANCISCO, CA
Phone:
Kategorie:
Healthcare
Anmerkungen:
Diese Pressemitteilung wurde bisher 142 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Medivation Announces Fourth Quarter and Year-End 2012 Financial Results Teleconference on February 28, 2013
"
steht unter der journalistisch-redaktionellen Verantwortung von
medivation (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
